Editorial
doi: 10.1136/bmj.326.7404.1407.
A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries
- PMID: 12829526
- PMCID: PMC1126301
- DOI: 10.1136/bmj.326.7404.1407
Item in Clipboard
Editorial
A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries
BMJ.
.
No abstract available
Comment in
-
"Polypill" to fight cardiovascular disease: patients before populations.BMJ. 2003 Oct 4;327(7418):807; discussion 809; author reply 809-10. doi: 10.1136/bmj.327.7418.807. BMJ. 2003. PMID: 14525888 Free PMC article. No abstract available.
-
"Polypill" to fight cardiovascular disease: cost effectiveness of statins for primary prevention of cardiovascular events is questionable.BMJ. 2003 Oct 4;327(7418):808-9; discussion 809; author reply 809-10. doi: 10.1136/bmj.327.7418.808-c. BMJ. 2003. PMID: 14525889 Free PMC article. No abstract available.
Comment on
-
A strategy to reduce cardiovascular disease by more than 80%.BMJ. 2003 Jun 28;326(7404):1419. doi: 10.1136/bmj.326.7404.1419. BMJ. 2003. PMID: 12829553 Free PMC article.
-
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.BMJ. 2003 Jun 28;326(7404):1423. doi: 10.1136/bmj.326.7404.1423. BMJ. 2003. PMID: 12829554 Free PMC article.
-
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.BMJ. 2003 Jun 28;326(7404):1427. doi: 10.1136/bmj.326.7404.1427. BMJ. 2003. PMID: 12829555 Free PMC article.
Similar articles
-
Polypill: Can its Potential Enhancement of Efficacy Trigger New Interest?Glob Heart. 2016 Dec;11(4):469-472. doi: 10.1016/j.gheart.2016.10.020. Glob Heart. 2016. PMID: 27938845 No abstract available.
-
The Polypill in the prevention of cardiovascular disease.Prev Med. 2011 Jan;52(1):16-7. doi: 10.1016/j.ypmed.2010.11.015. Epub 2010 Dec 2. Prev Med. 2011. PMID: 21130112 No abstract available.
-
A single pill for prevention?Harv Heart Lett. 2009 Jul;19(11):6. Harv Heart Lett. 2009. PMID: 19927382 No abstract available.
-
A polypill for all? Critical review of the polypill literature for primary prevention of cardiovascular disease and stroke.Ann Pharmacother. 2012 May;46(5):688-95. doi: 10.1345/aph.1Q621. Epub 2012 May 8. Ann Pharmacother. 2012. PMID: 22570437 Review.
-
Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population.Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):101-10. doi: 10.1038/ncpcardio1419. Epub 2008 Dec 23. Nat Clin Pract Cardiovasc Med. 2009. PMID: 19104519 Review.
Cited by
-
Prediction of cardiovascular disease risk among low-income urban dwellers in metropolitan Kuala Lumpur, Malaysia.Biomed Res Int. 2015;2015:516984. doi: 10.1155/2015/516984. Epub 2015 Mar 2. Biomed Res Int. 2015. PMID: 25821810 Free PMC article.
-
Credential evidences of Ayurvedic cardio-vascular herbs.Ayu. 2014 Apr;35(2):111-2. doi: 10.4103/0974-8520.146194. Ayu. 2014. PMID: 25558152 Free PMC article. No abstract available.
-
Population health: challenges for science and society.Milbank Q. 2007 Sep;85(3):533-59. doi: 10.1111/j.1468-0009.2007.00498.x. Milbank Q. 2007. PMID: 17718667 Free PMC article.
-
"Polypill" to fight cardiovascular disease: patients before populations.BMJ. 2003 Oct 4;327(7418):807; discussion 809; author reply 809-10. doi: 10.1136/bmj.327.7418.807. BMJ. 2003. PMID: 14525888 Free PMC article. No abstract available.
-
Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects.Am Heart J. 2011 Apr;161(4):719-25. doi: 10.1016/j.ahj.2010.12.019. Am Heart J. 2011. PMID: 21473971 Free PMC article.
References
-
- Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 2000;355: 1955-64. - PubMed
-
- Yusuf S. Two decades of progress in preventing vascular disease. Lancet 2002;360: 2-3. - PubMed
-
- Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, et al. Reducing the risk of cardiovascular disease: effectiveness and costs of interventions to reduce systolic blood pressure and cholesterol—a global and regional analysis. Lancet 2003;361: 717-25. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
